Search

Your search keyword '"Lee, Rachel M."' showing total 360 results
Start Over Author "Lee, Rachel M."
360 results on '"Lee, Rachel M."'

51. One limit, many options

Author

Lee, Rachel M., Carlson, Jane M., Bril, Jeremy S., Cramer, Jeremy, and Harenda, Jeff

Published
2016

52. A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients

Author

Zaidi, Mohammad Y., Lopez-Aguiar, Alexandra G., Switchenko, Jeffrey M., Lipscomb, Joseph, Andreasi, Valentina, Partelli, Stefano, Gamboa, Adriana C., Lee, Rachel M., Poultsides, George A., Dillhoff, Mary, Rocha, Flavio G., Idrees, Kamran, Cho, Clifford S., Weber, Sharon M., Fields, Ryan C., Staley, Charles A., III, Falconi, Massimo, and Maithel, Shishir K.

Published
2019
Full Text
View/download PDF

53. Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer

Author

Macedo, Francis I., Ryon, Emily, Maithel, Shishir K., Lee, Rachel M., Kooby, David A., Fields, Ryan C., Hawkins, William G., Williams, Greg, Maduekwe, Ugwuji, Kim, Hong J., Ahmad, Syed A., Patel, Sameer H., Abbott, Daniel E., Schwartz, Patrick, Weber, Sharon M., Scoggins, Charles R., Martin, Robert C. G., Dudeja, Vikas, Franceschi, Dido, Livingstone, Alan S., and Merchant, Nipun B.

Published
2019
Full Text
View/download PDF

54. Metastatic breast cancer cells have reduced calcium and actin response after ATP-P2Y2 signaling

Author

Mull, Makenzy L, primary, Pratt, Stephen J P, additional, Thompson, Keyata N, additional, Annis, David A, additional, Gad, Abanoub A, additional, Lee, Rachel M, additional, Chang, Katarina T, additional, Stemberger, Megan B, additional, Ju, Julia A, additional, Gilchrist, Darin E, additional, Boyman, Liron, additional, Vitolo, Michele I, additional, Lederer, W Jonathan, additional, and Martin, Stuart S, additional

Published
2023
Full Text
View/download PDF

55. Extracellular matrix assembly stress initiates Drosophila central nervous system morphogenesis

Author

Serna-Morales, Eduardo, primary, Sánchez-Sánchez, Besaiz J., additional, Marcotti, Stefania, additional, Nichols, Angus, additional, Bhargava, Anushka, additional, Dragu, Anca, additional, Hirvonen, Liisa M., additional, Díaz-de-la-Loza, María-del-Carmen, additional, Mink, Matyas, additional, Cox, Susan, additional, Rayfield, Emily, additional, Lee, Rachel M., additional, Hobson, Chad M., additional, Chew, Teng-Leong, additional, and Stramer, Brian M., additional

Published
2023
Full Text
View/download PDF

56. Elevation of Cytoplasmic Calcium Suppresses Microtentacle Formation and Function in Breast Tumor Cells

Author

Chang, Katarina T., primary, Thompson, Keyata N., additional, Pratt, Stephen J. P., additional, Ju, Julia A., additional, Lee, Rachel M., additional, Mathias, Trevor J., additional, Mull, Makenzy L., additional, Annis, David A., additional, Ory, Eleanor C., additional, Stemberger, Megan B., additional, Vitolo, Michele I., additional, and Martin, Stuart S., additional

Published
2023
Full Text
View/download PDF

60. Propagation dynamics of electrotactic motility in large epithelial cell sheets

Author

Zhang, Yan, primary, Xu, Guoqing, additional, Wu, Jiandong, additional, Lee, Rachel M, additional, Zhu, Zijie, additional, Sun, Yaohui, additional, Zhu, Kan, additional, Losert, Wolfgang, additional, Liao, Simon, additional, Zhang, Gong, additional, Pan, Tingrui, additional, Xu, Zhengping, additional, Lin, Francis, additional, and Zhao, Min, additional

Published
2022
Full Text
View/download PDF

63. Diagnostic laparoscopy is underutilized in the staging of gastric adenocarcinoma regardless of hospital type: An US safety net collaborative analysis

Author

Leder Macek, Aleeza J., primary, Wang, Annie, additional, Turgeon, Michael K., additional, Lee, Rachel M., additional, Russell, Maria C., additional, Porembka, Matthew R., additional, Alterio, Rodrigo, additional, Ju, Michelle, additional, Kronenfeld, Joshua, additional, Goel, Neha, additional, Datta, Jashodeep, additional, Maker, Ajay V., additional, Fernandez, Manuel, additional, Richter, Harry, additional, Berman, Russell S., additional, Correa‐Gallego, Camilo, additional, and Lee, Ann Y., additional

Published
2022
Full Text
View/download PDF

64. Diagnostic laparoscopy is underutilized in the staging of gastric adenocarcinoma regardless of hospital type: An US safety net collaborative analysis.

Author

Leder Macek, Aleeza J, Leder Macek, Aleeza J, Wang, Annie, Turgeon, Michael K, Lee, Rachel M, Russell, Maria C, Porembka, Matthew R, Alterio, Rodrigo, Ju, Michelle, Kronenfeld, Joshua, Goel, Neha, Datta, Jashodeep, Maker, Ajay V, Fernandez, Manuel, Richter, Harry, Berman, Russell S, Correa-Gallego, Camilo, Lee, Ann Y, Leder Macek, Aleeza J, Leder Macek, Aleeza J, Wang, Annie, Turgeon, Michael K, Lee, Rachel M, Russell, Maria C, Porembka, Matthew R, Alterio, Rodrigo, Ju, Michelle, Kronenfeld, Joshua, Goel, Neha, Datta, Jashodeep, Maker, Ajay V, Fernandez, Manuel, Richter, Harry, Berman, Russell S, Correa-Gallego, Camilo, and Lee, Ann Y

Abstract

BackgroundDiagnostic laparoscopy (DL) is a key component of staging for locally advanced gastric adenocarcinoma (GA). We hypothesized that utilization of DL varied between safety net (SNH) and affiliated tertiary referral centers (TRCs).MethodsPatients diagnosed with primary GA eligible for DL were identified from the US Safety Net Collaborative database (2012-2014). Clinicopathologic factors were analyzed for association with use of DL and findings on DL. Overall survival (OS) was analyzed by Kaplan-Meier method.ResultsAmong 233 eligible patients, 69 (30%) received DL, of which 24 (35%) were positive for metastatic disease. Forty percent of eligible SNH patients underwent DL compared to 21.5% at TRCs. Lack of insurance was significantly associated with decreased use of DL (OR 0.48, p < 0.01), while African American (OR 6.87, p = 0.02) and Asian race (OR 3.12, p ≤ 0.01), signet ring cells on biopsy (OR 3.14, p < 0.01), and distal tumors (OR 1.62, p < 0.01) were associated with increased use. Median OS of patients with a negative DL was better than those without DL or a positive DL (not reached vs. 32 vs. 12 months, p < 0.005, Figure 1).ConclusionsResults from DL are a strong predictor of OS in GA; however, the procedure is underutilized. Patients from racial minority groups were more likely to undergo DL, which likely accounts for higher DL rates among SNH patients.

Published
2022

65. Tubulin Carboxypeptidase Activity Promotes Focal Gelatin Degradation in Breast Tumor Cells and Induces Apoptosis in Breast Epithelial Cells That Is Overcome by Oncogenic Signaling

Author

Mathias, Trevor J., primary, Ju, Julia A., additional, Lee, Rachel M., additional, Thompson, Keyata N., additional, Mull, Makenzy L., additional, Annis, David A., additional, Chang, Katarina T., additional, Ory, Eleanor C., additional, Stemberger, Megan B., additional, Hotta, Takashi, additional, Ohi, Ryoma, additional, Vitolo, Michele I., additional, Moutin, Marie-Jo, additional, and Martin, Stuart S., additional

Published
2022
Full Text
View/download PDF

67. Additional file 2 of Microtubule disruption reduces metastasis more effectively than primary tumor growth

Author

Thompson, Keyata N., Ju, Julia A., Ory, Eleanor C., Pratt, Stephen J. P., Lee, Rachel M., Mathias, Trevor J., Chang, Katarina T., Lee, Cornell J., Goloubeva, Olga G., Bailey, Patrick C., Chakrabarti, Kristi R., Jewell, Christopher M., Vitolo, Michele I., and Martin, Stuart S.

Abstract

Additional file 2: Fig. S2. Cell viability after Vinorelbine treatment A) MDA-MB-231 TD cells treated with a dose range of Vinorelbine for 24 h (black) and 48 h (gray) shows a dose-dependent decrease in cell viability over time. Staurosporine (1 ��M) was used as a positive control to promote cell death and decrease cell viability. Vinorelbine (10 ��M) caused minimal toxicity after 24 h (black arrow). Data are shown as mean �� SD, n = 3. B) Representative brightfield images were taken for each condition using the Nikon Eclipse Ti2-E inverted microscope at 10 �� magnification. MDA-MB-231 TD cells treated with Vinorelbine (10 ��M) or Staurosporine (1 ��M) for 24 h and 48 h. Scale bar = 100 ��m. C) Cell viability assay with Vinorelbine (10 ��M, 24 h and 48 h) in MDA-MB-231 TD, MDA-MB-436 TD and BT-549 TD cell lines. Vinorelbine treatment for 24 h (black) and 48 h (gray) shows a similar dose-dependent response as shown in panel A. Staurosporine (1 ��M) shown in hatched bars, was compared to the Vinorelbine treatment and used a positive control for 24 h and 48 h. D) Representative phase contrast images of vehicle control and Vinorelbine-treated MDA-MB-436 TD and BT-549 TD cells over time to visualize cell attachment or lack of attachment (rounding). Panels taken at a 10 �� magnification. Scale bar = 100 ��m.

Published
2022
Full Text
View/download PDF

68. Additional file 6 of Microtubule disruption reduces metastasis more effectively than primary tumor growth

Author

Thompson, Keyata N., Ju, Julia A., Ory, Eleanor C., Pratt, Stephen J. P., Lee, Rachel M., Mathias, Trevor J., Chang, Katarina T., Lee, Cornell J., Goloubeva, Olga G., Bailey, Patrick C., Chakrabarti, Kristi R., Jewell, Christopher M., Vitolo, Michele I., and Martin, Stuart S.

Abstract

Additional file 6: Fig. S6. Lung retention and metastatic development in the presence of Vinorelbine. NSG/SCID mice treated with vehicle control (0.1% DMSO) or 5 mg/kg Vinorelbine during a single 24 h dose prior to injection with either the MDA-MB-436 TD or BT-549 TD cell lines. Animals were treated once at 24 h before cell inoculation due to the severe immune deficiency of the host animal. A) Representative bioluminescence images of mice treated and injected with MDA-MB-436 TD cells. In the MDA-MB-436 TD line, the vehicle control population resulted in 5 out of 5 animals (100%) exhibiting tumor formation in lung tissue at 7 weeks post inoculation with 4/5 (80%) surviving. The surviving vehicle control animals all have at least a tenfold increase over the initial bioluminescence value. The Vinorelbine treatment resulted in 8 out of 8 animals (100%) with disease-free survival at 7 weeks. The surviving Vinorelbine treated animals did not meet or exceed their initial value. B) Fold differences of retained bioluminescence in the lung of animals inoculated MDA-MB-436 TD cells via tail vein. C) Representative bioluminescence images of mice treated and injected with BT-549 TD cells. The BT-549 TD cells treated with the vehicle control resulted in 4 out of 5 animals (80%) exhibiting tumor formation in lung tissue at 7 weeks post inoculation with 5/5 (100%) surviving. 4/5 (80%) of the surviving vehicle control animals have a minimum of a twofold increase over the initial bioluminescence value. The Vinorelbine treatment resulted in 7 out of 8 animals (87.5%) with disease-free survival at 7 weeks. The surviving Vinorelbine treated animals did not meet or exceed their initial value. Photon flux color scale is shown to the right. Data represent individual animal examined and measured as a fold change of the initial value of each independent animal.

Published
2022
Full Text
View/download PDF

69. Additional file 7 of Microtubule disruption reduces metastasis more effectively than primary tumor growth

Author

Thompson, Keyata N., Ju, Julia A., Ory, Eleanor C., Pratt, Stephen J. P., Lee, Rachel M., Mathias, Trevor J., Chang, Katarina T., Lee, Cornell J., Goloubeva, Olga G., Bailey, Patrick C., Chakrabarti, Kristi R., Jewell, Christopher M., Vitolo, Michele I., and Martin, Stuart S.

Abstract

Additional file 7: Fig. S7. Vinorelbine treatment does not significantly reduce early lung retention. A. Representative bioluminescence images of mice after introducing the MDA-MB-231 TD cells via tail vein. Mice received 2 injections (24 h and 2 h) of DMSO control (0.1%) or Vinorelbine (5 mg/kg) prior to cell inoculation and imaging. At all timepoints, there is slightly lower lung bioluminescence in Vinorelbine-treated mice, but the average differences (B) do not reach statistical significance (P = 0.556).

Published
2022
Full Text
View/download PDF

70. Additional file 4 of Microtubule disruption reduces metastasis more effectively than primary tumor growth

Author

Thompson, Keyata N., Ju, Julia A., Ory, Eleanor C., Pratt, Stephen J. P., Lee, Rachel M., Mathias, Trevor J., Chang, Katarina T., Lee, Cornell J., Goloubeva, Olga G., Bailey, Patrick C., Chakrabarti, Kristi R., Jewell, Christopher M., Vitolo, Michele I., and Martin, Stuart S.

Abstract

Additional file 4: Fig. S4. Vinorelbine treatment decreases tumor cell reattachment. A) Reattachment efficiency of the MDA-MB-436 TD and BT-549 TD cells treated with Vinorelbine (10 ��M) is significantly lower than vehicle control treated cells (0.1% DMSO). Changes in impedance are apparent as early as 4 h and significant differences continue for 24 h after initial seeding. Representative experiment from three independent experiments; each performed in quadruplicate. B) Representative brightfield images of MDA-MB-436 TD and Bt-549 cells. Images were taken at 10 �� magnification at 0, 24, and 48 h in vehicle control, (0.1% DMSO). Vinorelbine (10 ��M), and Staurosporine(1 ��M). Scale bar = 100 ��m.

Published
2022
Full Text
View/download PDF

71. Additional file 1 of Microtubule disruption reduces metastasis more effectively than primary tumor growth

Author

Thompson, Keyata N., Ju, Julia A., Ory, Eleanor C., Pratt, Stephen J. P., Lee, Rachel M., Mathias, Trevor J., Chang, Katarina T., Lee, Cornell J., Goloubeva, Olga G., Bailey, Patrick C., Chakrabarti, Kristi R., Jewell, Christopher M., Vitolo, Michele I., and Martin, Stuart S.

Abstract

Additional file 1: Fig. S1. Vinorelbine decreases McTNs and perimeter on breast tumor cells. MDA-MB-231 TD, MDA-MB-436 TD and BT-549 TD cells were tethered onto a TetherChip surface and stained with the cell membrane dye WGA (1:100) and nuclear dye Hoechst 33,258 (1:5000). A) Representative confocal images taken at 60 �� magnification using an Olympus IX81 microscope with a Fluoview FV1000 confocal laser scanning system. Scale bars correspond to 10 ��m. B) Vinorelbine treatment (10 ��M) for 1 h. results in a significant decrease in McTN frequency (%) compared to vehicle control. McTN scoring consists of mean values from four independent experiments where 100 cells were blindly counted and averaged. C) Twenty cells imaged from panel (A) were analyzed for perimeter quantification using Fiji ImageJ. Compared to the vehicle control treated MDA-MB-231 TD, MDA-MB-436 TD and BT-549 TD cells, Vinorelbine significantly reduced the perimeter of cells. A reduction in perimeter of a cell correlates with less McTNs. D) Representative raw images of tethered cells and computer determined cell body outline (blue), cell perimeter (red), and McTNs tips (yellow). E) Live cell analysis measuring an average number of McTN tips for cells treated with vehicle and Vinorelbine (10 ��M, 1 h.). McTN number is the number of McTNs per cell. McTN distance is average distance of McTN tips from cell body boundary. For live cell image analysis, a population of 25 cells per condition was analyzed from 3 independent experimental replicate.

Published
2022
Full Text
View/download PDF

72. Additional file 5 of Microtubule disruption reduces metastasis more effectively than primary tumor growth

Author

Thompson, Keyata N., Ju, Julia A., Ory, Eleanor C., Pratt, Stephen J. P., Lee, Rachel M., Mathias, Trevor J., Chang, Katarina T., Lee, Cornell J., Goloubeva, Olga G., Bailey, Patrick C., Chakrabarti, Kristi R., Jewell, Christopher M., Vitolo, Michele I., and Martin, Stuart S.

Abstract

Additional file 5: Fig. S5. Vinorelbine treatment decreases homotypic cluster aggregation in vitro. Representative Hoechst stained images of the full ROI region of the ibidi slide. Images of control and Vinorelbine-treated MDA-MB-231 TD, MDA-MB-436 TD and BT-549 TD cells imaged over time to visualize cluster formation efficiency. Images taken at 4 �� magnification.

Published
2022
Full Text
View/download PDF

73. Additional file 3 of Microtubule disruption reduces metastasis more effectively than primary tumor growth

Author

Thompson, Keyata N., Ju, Julia A., Ory, Eleanor C., Pratt, Stephen J. P., Lee, Rachel M., Mathias, Trevor J., Chang, Katarina T., Lee, Cornell J., Goloubeva, Olga G., Bailey, Patrick C., Chakrabarti, Kristi R., Jewell, Christopher M., Vitolo, Michele I., and Martin, Stuart S.

Subjects
macromolecular substances
Abstract

Additional file 3: Fig. S3. Vinorelbine decreases the filamentous microtubule network. A) Immunoblot analysis of Vinorelbine (10 ��M) treated MDA-MB-436 TD and BT-549 TD for 24 h and 48 h. The cytoskeletal post-translational modification acetylated tubulin (acetyl-tubulin) and total ��-tubulin remain unchanged at 24 h and 48 h, compared with vehicle control (0.1% DMSO). Vinorelbine treatment in both the MDA-MB-436 TD and BT-549 TD decreases detyrosinated tubulin (Glu-tubulin) with time. B) Representative immunofluorescence images of tethered and fixed MDA-MB-436 TD and BT-549 TD after 1 h treatment of Vinorelbine (10 ��M). The filamentous tubulin structures (acetyl-tubulin, and glu-tubulin) are destroyed (green), while the nuclear stain Hoechst (blue) remains intact. Cells were stained with Hoechst 33,258 (1:5000, blue), ��-tubulin, acetyl-tubulin, and glu-tubulin (1:1000, green) and were taken at 40 �� magnification using an Olympus IX81 microscope with a Fluoview FV1000 confocal laser scanning system. Scale bar = 10 ��m.

Published
2022
Full Text
View/download PDF

75. A novel preoperative risk score to guide patient selection for resection of soft tissue sarcoma lung metastases: An analysis from the United States Sarcoma Collaborative

Author

Lee, Rachel M., primary, Ethun, Cecilia G., additional, Gamboa, Adriana C., additional, Turgeon, Michael K., additional, Tran, Thuy, additional, Poultsides, George, additional, Grignol, Valerie, additional, Bedi, Meena, additional, Mogal, Harveshp, additional, Clarke, Callisia N., additional, Tseng, Jennifer, additional, Roggin, Kevin K., additional, Chouliaras, Konstantinos, additional, Votanopoulos, Konstantinos, additional, Krasnick, Bradley A., additional, Fields, Ryan C., additional, Oskouei, Shervin V., additional, Monson, David K., additional, Reimer, Nickolas B., additional, Maithel, Shishir K., additional, Pickens, Allan, additional, and Cardona, Kenneth, additional

Published
2021
Full Text
View/download PDF

77. Surgical resection of early stage hepatocellular carcinoma improves patient survival at safety net hospitals

Author

Vitiello, Gerardo A., primary, Wang, Annie, additional, Lee, Rachel M., additional, Russell, Maria C., additional, Yopp, Adam, additional, Ryon, Emily L., additional, Goel, Neha, additional, Luu, Sommer, additional, Hsu, Cary, additional, Silberfein, Eric, additional, Correa‐Gallego, Camilo, additional, Berman, Russell S., additional, and Lee, Ann Y., additional

Published
2021
Full Text
View/download PDF

78. Primary mesenteric sarcomas: Collaborative experience from the Trans‐Atlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)

Author

Tattersall, Hannah L., primary, Hodson, James, additional, Cardona, Kenneth, additional, Lee, Rachel M., additional, Nessim, Carolyn, additional, Gladdy, Rebecca, additional, Van Der Hage, Jos, additional, Schrage, Yvonne, additional, Tseng, William W., additional, Houdt, Winan, additional, Novak, Marko, additional, Grignani, Giovanni, additional, Tolomeo, Francesco, additional, Goel, Neha, additional, Ryon, Emily, additional, Gyorki, David, additional, Bagaria, Sanjay P., additional, Gonzalez, Jose A., additional, Arnau, Ana B. M., additional, Sayyed, Raza, additional, Tirotta, Fabio, additional, Evenden, Caroline, additional, Desai, Anant, additional, Almond, Max, additional, Glasbey, James, additional, Fiore, Marco, additional, Gronchi, Alessandro, additional, and Ford, Samuel J., additional

Published
2020
Full Text
View/download PDF

79. Defining the role of neoadjuvant systemic therapy in high‐risk retroperitoneal sarcoma: A multi‐institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group

Author

Tseng, William W., primary, Barretta, Francesco, additional, Conti, Lorenzo, additional, Grignani, Giovanni, additional, Tolomeo, Francesco, additional, Albertsmeier, Markus, additional, Angele, Martin K., additional, Rutkowski, Piotr, additional, Skoczylas, Jacek, additional, De Paoli, Antonino, additional, Navarria, Federico, additional, Raut, Chandrajit P., additional, Fairweather, Mark, additional, Farma, Jeffrey M., additional, Nessim, Carolyn, additional, Goel, Neha, additional, Grignol, Valerie P., additional, Ford, Samuel J., additional, Cardona, Kenneth, additional, Subhawong, Ty, additional, Tattersall, Hannah L., additional, Lee, Rachel M., additional, Hu, James S., additional, Mehren, Margaret, additional, Sanfilippo, Roberta, additional, and Gronchi, Alessandro, additional

Published
2020
Full Text
View/download PDF

80. Surgical management of hepatocellular carcinoma patients with portal vein thrombosis: The United States Safety Net and Academic Center Collaborative Analysis

Author

Ryon, Emily L., primary, Kronenfeld, Joshua P., additional, Lee, Rachel M., additional, Yopp, Adam, additional, Wang, Annie, additional, Lee, Ann Y., additional, Luu, Sommer, additional, Hsu, Cary, additional, Silberfein, Eric, additional, Russell, Maria C., additional, Goel, Neha, additional, Merchant, Nipun B., additional, and Datta, Jashodeep, additional

Published
2020
Full Text
View/download PDF

82. Insurance Matters! Disparities in Treatment and Outcomes Based on Insurance Status of Patients with Early-Stage Hepatocellular Carcinoma: A US Safety-Net Collaborative Analysis

Author

Kronenfeld, Joshua P., primary, Ryon, Emily L., additional, Lee, Rachel M., additional, Charles Yopp, Adam, additional, Yeelin Lee, Ann, additional, Hsu, Cary, additional, Jay Silberfein, Eric, additional, Citarella Russell, Maria, additional, Merchant, Nipun B., additional, and Goel, Neha, additional

Published
2020
Full Text
View/download PDF

83. A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC

Author

Lee, Rachel M., primary, Gamboa, Adriana C., additional, Turgeon, Michael K., additional, Zaidi, Mohammad Y., additional, Kimbrough, Charles, additional, Leiting, Jennifer, additional, Grotz, Travis, additional, Lee, Andrew J., additional, Fournier, Keith, additional, Powers, Benjamin, additional, Dineen, Sean, additional, Baumgartner, Joel M., additional, Veerapong, Jula, additional, Mogal, Harveshp, additional, Clarke, Callisia, additional, Wilson, Gregory, additional, Patel, Sameer, additional, Hendrix, Ryan, additional, Lambert, Laura, additional, Pokrzywa, Courtney, additional, Abbott, Daniel E., additional, LaRocca, Christopher J., additional, Raoof, Mustafa, additional, Greer, Jonathan, additional, Johnston, Fabian M., additional, Staley, Charles A., additional, Cloyd, Jordan M., additional, Maithel, Shishir K., additional, and Russell, Maria C., additional

Published
2020
Full Text
View/download PDF

84. Patient Selection for Hepatocellular Carcinoma Resection in Child a Cirrhosis Can Be Limited by Disease Presentation at Safety Net Hospitals vs Academic Centers

Author

Vitiello, Gerardo A., primary, Lee, Rachel M., additional, Russell, Maria Citarella, additional, Charles Yopp, Adam, additional, Ryon, Emily Leah, additional, Goel, Neha, additional, Luu, Sommer V., additional, Hsu, Cary, additional, Silberfein, Eric Jay, additional, and Lee, Ann Y., additional

Published
2020
Full Text
View/download PDF

85. Disparities in Presentation at Time of Hepatocellular Carcinoma Diagnosis: A United States Safety-Net Collaborative Study

Author

Kronenfeld, Joshua P., primary, Ryon, Emily L., additional, Goldberg, David, additional, Lee, Rachel M., additional, Yopp, Adam, additional, Wang, Annie, additional, Lee, Ann Y., additional, Luu, Sommer, additional, Hsu, Cary, additional, Silberfein, Eric, additional, Russell, Maria C., additional, Livingstone, Alan S., additional, Merchant, Nipun B., additional, and Goel, Neha, additional

Published
2020
Full Text
View/download PDF

86. Impact of Postoperative Complications on Oncologic Outcomes After Rectal Cancer Surgery: An Analysis of the US Rectal Cancer Consortium

Author

Gamboa, Adriana C., primary, Lee, Rachel M., additional, Turgeon, Michael K., additional, Varlamos, Christopher, additional, Regenbogen, Scott E., additional, Hrebinko, Katherine A., additional, Holder-Murray, Jennifer, additional, Wiseman, Jason T., additional, Ejaz, Aslam, additional, Feng, Michael P., additional, Hawkins, Alexander T., additional, Bauer, Philip, additional, Silviera, Matthew, additional, Maithel, Shishir K., additional, and Balch, Glen C., additional

Published
2020
Full Text
View/download PDF

87. Abstract 2575: Mechanoactivation of NOX2-generated ROS elicits persistent TRPM8 Ca2+ signals that are inhibited by oncogenic KRas

Author

Pratt, Stephen JP, primary, Lee, Rachel M., additional, Hernandez-Ochoa, Erick O., additional, Ory, Eleanor C., additional, Thompson, Keyata N., additional, Bailey, Patrick C., additional, Mathias, Trevor J., additional, Ju, Julia A., additional, Vitolo, Michele I., additional, Schneider, Martin F., additional, Stains, Joseph P., additional, Ward, Christopher W., additional, and Martin, Stuart S., additional

Published
2020
Full Text
View/download PDF

89. The Evolving Landscape of Hepatocellular Carcinoma

Author

Lee, Rachel M., primary, Gamboa, Adriana C., additional, Turgeon, Michael K., additional, Yopp, Adam, additional, Ryon, Emily L., additional, Kronenfeld, Joshua P., additional, Goel, Neha, additional, Wang, Annie, additional, Lee, Ann Y., additional, Luu, Sommer, additional, Hsu, Cary, additional, Silberfein, Eric, additional, Maithel, Shishir K., additional, and Russell, Maria C., additional

Published
2020
Full Text
View/download PDF

90. Should Signet Ring Cell Histology Alter the Treatment Approach for Clinical Stage I Gastric Cancer?

Author

Turgeon, Michael K., primary, Gamboa, Adriana C., additional, Rupji, Manali, additional, Lee, Rachel M., additional, Switchenko, Jeffrey M., additional, El-Rayes, Bassel F., additional, Russell, Maria C., additional, Cardona, Kenneth, additional, Kooby, David A., additional, Staley, Charles A., additional, Maithel, Shishir K., additional, and Shah, Mihir M., additional

Published
2020
Full Text
View/download PDF

93. Optimal timing and treatment strategy for pancreatic cancer

Author

Gamboa, Adriana C., primary, Rupji, Manali, additional, Switchenko, Jeffrey M., additional, Lee, Rachel M., additional, Turgeon, Michael K., additional, Meyer, Benjamin I., additional, Russell, Maria C., additional, Cardona, Kenneth, additional, Kooby, David A., additional, Maithel, Shishir K., additional, and Shah, Mihir M., additional

Published
2020
Full Text
View/download PDF

96. Revisiting the value of drains after low anterior resection for rectal cancer: An analysis of 996 patients.

Author

Lee, Rachel M., primary, Gamboa, Adriana C., additional, Turgeon, Michael K., additional, Prasad, Sanjana, additional, Kwakye, Gifty, additional, Hrebinko, Katherine, additional, Holder-Murray, Jennifer, additional, Abdel-Misih, Sherif, additional, Kimbrough, Charles, additional, Soda, Mosope, additional, Hawkins, Alexander, additional, Chapman, William C., additional, Silviera, Matthew, additional, Maithel, Shishir K., additional, and Balch, Glen C., additional

Published
2020
Full Text
View/download PDF

97. Implications of postoperative complications on survival after cytoreductive surgery and HIPEC: A multi-institutional analysis of the United States HIPEC Collaborative.

Author

Gamboa, Adriana C., primary, Lee, Rachel M., additional, Turgeon, Michael K., additional, Ahmed, Ahmed, additional, Grotz, Travis Edward, additional, Fournier, Keith F., additional, Dineen, Sean Patrick, additional, Veerapong, Jula, additional, Clarke, Callisia, additional, Mogal, Harveshp, additional, Patel, Sameer H., additional, Lambert, Laura A., additional, Abbott, Daniel Erik, additional, Raoof, Mustafa, additional, Johnston, Fabian McCartney, additional, Cloyd, Jordan, additional, Maithel, Shishir K., additional, and Staley, Charles A., additional

Published
2020
Full Text
View/download PDF

98. Impact of postoperative complications on oncologic outcomes after rectal cancer surgery: An analysis of the United States Rectal Cancer Consortium.

Author

Gamboa, Adriana C., primary, Lee, Rachel M., additional, Turgeon, Michael K., additional, Varlamos, Christopher, additional, Regenbogen, Scott E., additional, Hrebinko, Katherine, additional, Holder-Murray, Jennifer, additional, Wiseman, Jason T., additional, Ejaz, Aslam, additional, Feng, Michael P., additional, Hawkins, Alexander, additional, Bauer, Philip, additional, Silviera, Matthew, additional, Maithel, Shishir K., additional, and Balch, Glen C., additional

Published
2020
Full Text
View/download PDF

99. A United States Rectal Cancer Consortium study of inferior mesenteric artery versus superior rectal artery ligation: How high do we need to go?

Author

Turgeon, Michael K., primary, Gamboa, Adriana C., additional, Lee, Rachel M., additional, Maniko, Jeffrey, additional, Maguire, Lillias, additional, Mohammed, Maryam, additional, Holder-Murray, Jennifer, additional, Abdel-Misih, Sherif, additional, Kimbrough, Charles, additional, Wiseman, Jason T., additional, Edwards-Hollingsworth, Kamren, additional, Hawkins, Alexander, additional, Bauer, Philip, additional, Silviera, Matthew, additional, Maithel, Shishir K., additional, and Balch, Glen C., additional

Published
2020
Full Text
View/download PDF

100. The intersection of age and tumor biology with postoperative outcomes in patients after cytoreductive surgery and HIPEC.

Author

Turgeon, Michael K., primary, Gamboa, Adriana C., additional, Lee, Rachel M., additional, Zaidi, Mohammad Yahya, additional, Kimbrough, Charles, additional, Grotz, Travis Edward, additional, Fournier, Keith F., additional, Dineen, Sean Patrick, additional, Veerapong, Jula, additional, Clarke, Callisia, additional, Mogal, Harveshp, additional, Patel, Sameer H., additional, Lambert, Laura A., additional, Ronnekleiv-Kelly, Sean, additional, Raoof, Mustafa, additional, Johnston, Fabian McCartney, additional, Staley, Charles A., additional, Cloyd, Jordan, additional, Maithel, Shishir K., additional, and Winer, Joshua H., additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results